SAB Biotherapeutics, Inc. (SABS) shares outstanding

Shares outstanding · fiscal 2025
61.34M

SAB Biotherapeutics, Inc. (SABS) had 61.34M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 562.3% higher than the 9.26M of fiscal 2024. Figures as of 18 Nov 2026, 12:08 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
61.34M
Change on fiscal 2024
+562.3%
Growth, 5 years
+86.7% a year
Highest on record
61.34Mfiscal 2025
Lowest on record
2.70Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

SAB Biotherapeutics, Inc. shares outstanding, in more detail

The market data feed counts 90.09M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 86.7% a year. Across the 6 fiscal years on record (2020–2025), the highest was 61.34M in fiscal 2025 and the lowest 2.70M in fiscal 2020.

History · 6 fiscal years

Shares outstanding by fiscal year

SAB Biotherapeutics, Inc. shares outstanding, year by year

SAB Biotherapeutics, Inc. (SABS) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202561.34M 562.3% up
20249.26M 67.7% up
20235.52M 26.9% up
20224.35M 59.2% up
20212.73M 1.2% up
20202.70M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on SABS

SAB Biotherapeutics, Inc., figure by figure

SAB Biotherapeutics, Inc. (SABS) overview: price, valuation and scorecard

SAB Biotherapeutics, Inc. shares outstanding: questions and answers

How many shares does SAB Biotherapeutics, Inc. have?

SAB Biotherapeutics, Inc. (SABS) had 61.34M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 562.3% higher than the 9.26M of fiscal 2024. The market data feed counts 90.09M shares outstanding today.

What is the growth rate of SAB Biotherapeutics, Inc.'s diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 86.7% a year.

What are the highest and lowest diluted share count figures on record for SAB Biotherapeutics, Inc.?

Across the 6 fiscal years on record (2020–2025), the highest was 61.34M in fiscal 2025 and the lowest 2.70M in fiscal 2020.

How is SAB Biotherapeutics, Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For SAB Biotherapeutics, Inc. it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “SAB Biotherapeutics, Inc. (SABS) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/SABS/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.